Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?
- PMID: 33932487
- DOI: 10.1016/j.jhep.2021.04.025
Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?
Keywords: end stage liver disease; heart disease; outcomes in cirrhosis.
Conflict of interest statement
Conflict of interest The authors have no conflicts of interest pertinent to this study. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?".J Hepatol. 2021 Oct;75(4):993-994. doi: 10.1016/j.jhep.2021.06.026. Epub 2021 Jul 2. J Hepatol. 2021. PMID: 34224780 No abstract available.
Comment on
-
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.J Hepatol. 2020 Oct;73(4):829-841. doi: 10.1016/j.jhep.2020.03.048. Epub 2020 Apr 13. J Hepatol. 2020. PMID: 32298768
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical